HSE - PCRS

Application Details

HSE Application ID

HSE100058

HTA Number

25045

HTA Link

https://www.ncpe.ie/polihexanide-akantior-hta-id-25045/

Drug

polihexanide

Brand

Akantior®

Applicant

Avanzanite Bioscience BV

Indication Applied For

Indicated for the treatment of Acanthamoeba keratitis in adults and children from 12 years of age.

Application Date

10/07/2025

Marketing Authorisation Date

22/08/2024

Application Status

HSE Rare Disease Technology Review Committee - Review Requested

12/02/2026

Reviewed by HSE Drugs Group

10/02/2026

HSE Drugs Group Review Pending

28/10/2025

Proposal from Applicant Under Review

03/10/2025

Awaiting Proposal from Applicant

11/09/2025

Applicant Meeting Held with CPU

11/09/2025

Rapid Review Completed

14/08/2025

Rapid Review Commissioned

10/07/2025

Pricing and Reimbursement Application Complete

10/07/2025